Health Condition 1: null- PSYCHOSIS
Conditions
Interventions
Intervention1: BLONANSERIN: 4MG TABLETS BD: BLONANSERIN 4MG TABLETS WILL BE GIVEN ORALLY WITH FOOD TWO TIMES A DAY (MORNING AND NIGHT) FOR 8 WEEKS DURATION.
Control Intervention1: AMISULPRIDE: 200MG
Sponsors
MYSORE MEDICAL COLLEGE AND RESEARCH INSTITUTE
Dr BM PARASHIVAMURTHY
Dr RAVEESH BN
Eligibility
Inclusion criteria
Inclusion criteria: •Age between 18 - 60 years. •Both sexes. •Subjects with recent onset of psychotic symptoms and those with past history of psychotic symptoms having recurrence of psychotic symptoms currently. •Subjects who give informed consent.
Exclusion criteria
Exclusion criteria: •Subjects with suicidal tendencies. •Subjects having diabetes mellitus and abnormal lipid profile. •Acute infections or any serious concurrent illness. •Presence of organic brain syndrome (delirium, dementia). •Presence of alcohol and substance abuse/dependence, epilepsy, mental retardation, pregnancy and lactation. •Subjects who are on or who have received other antipsychotics in the last year. •Non complying subjects who are unable to give consent for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A)ANTHROPOMETRY - WEIGHT, BMI (BODY MASS INDEX) AND WAIST HIP RATIO. B)BLOOD INVESTIGATIONS - BLOOD SUGAR LEVELS (FBS, PPBS) AND LIPID PROFILE. Timepoint: DONE AT 4 WEEKS AND 8 WEEKS. | — |
Secondary
| Measure | Time frame |
|---|---|
| ADVERSE DRUG REACTIONS, MEDICATION COMPLIANCETimepoint: DONE AT BASELINE(BEFORE STARTING THE DRUG), 4WEEKS AND 8 WEEKS. | — |
Countries
India
Contacts
Public ContactDr DEEPAK TS
MYSORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, MYSORE
Outcome results
None listed